Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review

GE Palomaki, LA Bradley, MP Douglas, K Kolor… - Genetics in …, 2009 - nature.com
This evidence-based review addresses the question of whether testing for UGT1A1
mutations in patients with metastatic colorectal cancer treated with irinotecan leads to …

Genetic variation analyses by Pyrosequencing

T Langaee, M Ronaghi - Mutation Research/Fundamental and Molecular …, 2005 - Elsevier
Pyrosequencing is a real-time bioluminometric technique for determination of nucleic acid
sequence. Here, we review recent advances and discuss new applications of this technique …

Risk factors for severe hyperbilirubinemia in neonates

MJ Huang, KE Kua, HC Teng, KS Tang, HW Weng… - Pediatric …, 2004 - nature.com
The incidence of severe neonatal hyperbilirubinemia is higher in Asians than in whites. A
case-control study was designed to investigate the effects of eight known risk factors [breast …

Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients

E Rouits, M Boisdron-Celle, A Dumont, O Guérin… - Clinical Cancer …, 2004 - AACR
Purpose: We wanted to assess polymorphisms in the uridine diphosphoglucuronosyl
transferase 1A1 (UGT 1A1) gene: the TATA box polymorphism and UGT 1A1 G71R and …

UGT1A1 Haplotypes Associated with Reduced Glucuronidation and Increased Serum Bilirubin in Irinotecan‐administered Japanese Patients with Cancer

K Sai, M Saeki, Y Saito, S Ozawa… - Clinical …, 2004 - Wiley Online Library
Purpose A comprehensive haplotype analysis of UGT1A1 in the Japanese population was
conducted, and the effects of these haplotypes were investigated with respect to UGT1A1 …

Irinotecan‐induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein

FA De Jong, TJ Scott‐Horton, DL Kroetz… - Clinical …, 2007 - Wiley Online Library
Interindividual pharmacokinetic variability of the anticancer agent irinotecan is high. Life‐
threatening diarrhea is observed in up to 25% of patients receiving irinotecan and has been …

Predicting drug response and toxicity based on gene polymorphisms

J Robert, V Le Morvan, D Smith, P Pourquier… - Critical reviews in …, 2005 - Elsevier
The sequencing of the human genome has allowed the identification of thousands of gene
polymorphisms, most often single nucleotide polymorphims (SNP), which may play an …

Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations

A Zhang, Q Xing, S Qin, J Du, L Wang, L Yu… - The …, 2007 - nature.com
Variants within the human UGT1A1 gene are associated with irinotecan induced severely
adverse reactions and hyperbilirubinemia. Intra-ethnic differences in the genetic variation …

Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk

TR Rebbeck, AB Troxel, Y Wang… - Journal of the …, 2006 - academic.oup.com
Background: Unopposed estrogen replacement therapy is associated with increased risk of
endometrial cancer. To investigate the mechanism of this association, we evaluated whether …

Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer

M Li, Z Wang, J Guo, J Liu, C Li, L Liu, H Shi… - OncoTargets and …, 2014 - Taylor & Francis
Purpose The primary aim of this research was to investigate the association between uridine
diphosphate glucuronosyltransferase (UGT) 1A1 gene polymorphisms and the toxicities of …